Free Trial

Tempus AI (NASDAQ:TEM) Shares Gap Down - Should You Sell?

Tempus AI logo with Medical background

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $65.87, but opened at $63.99. Tempus AI shares last traded at $56.35, with a volume of 11,619,197 shares.

Wall Street Analyst Weigh In

TEM has been the topic of several recent analyst reports. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. JPMorgan Chase & Co. downgraded shares of Tempus AI from an "overweight" rating to a "neutral" rating and raised their price target for the stock from $50.00 to $55.00 in a research note on Tuesday, February 25th. BTIG Research initiated coverage on shares of Tempus AI in a research note on Monday, April 21st. They issued a "buy" rating and a $60.00 price target on the stock. Piper Sandler raised their price target on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Finally, William Blair reaffirmed a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $63.42.

Get Our Latest Research Report on Tempus AI

Tempus AI Trading Up 0.3%

The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The company's fifty day simple moving average is $52.07 and its 200-day simple moving average is $51.90. The company has a market capitalization of $9.40 billion and a P/E ratio of -7.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. The business's quarterly revenue was up 75.4% on a year-over-year basis. Research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Activity

In related news, CEO Eric P. Lefkofsky sold 562,345 shares of the stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $50.93, for a total value of $28,640,230.85. Following the completion of the transaction, the chief executive officer now directly owns 9,457,283 shares of the company's stock, valued at $481,659,423.19. This trade represents a 5.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the transaction, the director now directly owns 26,514 shares of the company's stock, valued at $1,207,447.56. The trade was a 10.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 723,042 shares of company stock worth $37,642,690. Corporate insiders own 27.60% of the company's stock.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently modified their holdings of TEM. Operose Advisors LLC purchased a new position in shares of Tempus AI in the 4th quarter valued at approximately $25,000. Cherry Tree Wealth Management LLC purchased a new position in shares of Tempus AI in the 1st quarter valued at approximately $31,000. University of Texas Texas AM Investment Management Co. purchased a new position in shares of Tempus AI in the 1st quarter valued at approximately $33,000. Farther Finance Advisors LLC purchased a new position in shares of Tempus AI in the 4th quarter valued at approximately $34,000. Finally, Prestige Wealth Management Group LLC raised its position in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after purchasing an additional 965 shares during the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read More

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines